| 5093 | Humans |
| 3037 | Female |
| 2824 | Male |
| 1542 | Middle Aged |
| 1487 | Adult |
| 1302 | Animals |
| 1159 | Aged |
| 686 | Adolescent |
| 657 | Young Adult |
| 576 | Treatment Outcome |
| 484 | Aged, 80 and over |
| 474 | Retrospective Studies |
| 473 | Child |
| 459 | Mice |
| 420 | Risk Factors |
| 343 | United States |
| 314 | Time Factors |
| 305 | Prospective Studies |
| 305 | Follow-Up Studies |
| 247 | Cohort Studies |
| 234 | Child, Preschool |
| 217 | Surveys and Questionnaires |
| 200 | Prognosis |
| 195 | Reproducibility of Results |
| 190 | Disease Models, Animal |
| 184 | Infant |
| 180 | Rats |
| 176 | Pregnancy |
| 173 | Magnetic Resonance Imaging |
| 172 | Cross-Sectional Studies |
| 170 | United States (epidemiology) |
| 170 | Age Factors |
| 162 | Case-Control Studies |
| 161 | Mice, Inbred C57BL |
| 152 | Cell Line, Tumor |
| 149 | Severity of Illness Index |
| 149 | Cells, Cultured |
| 135 | Longitudinal Studies |
| 132 | Rats, Sprague-Dawley |
| 129 | Incidence |
| 128 | Algorithms |
| 122 | Predictive Value of Tests |
| 117 | Infant, Newborn |
| 113 | Mutation |
| 112 | Signal Transduction |
| 112 | Risk Assessment |
| 112 | Phenotype |
| 110 | Cell Line |
| 101 | Sensitivity and Specificity |
| 100 | Mice, Knockout |
| 100 | Body Mass Index |
| 99 | Genotype |
| 98 | Logistic Models |
| 95 | Computer Simulation |
| 92 | Pennsylvania |
| 89 | Quality of Life |
| 88 | Tomography, X-Ray Computed |
| 88 | Comorbidity |
| 87 | Prevalence |
| 86 | Models, Biological |
| 84 | Protein Binding |
| 82 | Sex Factors |
| 81 | Neoplasm Staging |
| 80 | Molecular Sequence Data |
| 80 | Disease Progression |
| 79 | Neuropsychological Tests |
| 79 | Immunohistochemistry |
| 78 | Models, Molecular |
| 77 | Magnetic Resonance Imaging (methods) |
| 76 | Mice, Transgenic |
| 76 | Genetic Predisposition to Disease |
| 73 | Dose-Response Relationship, Drug |
| 71 | Survival Rate |
| 71 | Multivariate Analysis |
| 71 | Diagnosis, Differential |
| 70 | Kaplan-Meier Estimate |
| 70 | Cell Proliferation |
| 68 | Biomarkers (blood) |
| 66 | Proportional Hazards Models |
| 64 | Equipment Design |
| 62 | Polymorphism, Single Nucleotide |
| 61 | Survival Analysis |
| 61 | Double-Blind Method |
| 61 | Amino Acid Sequence |
| 59 | Pilot Projects |
| 58 | Biomechanical Phenomena |
| 57 | Risk |
| 57 | Databases, Factual |
| 56 | Disease-Free Survival |
| 54 | Socioeconomic Factors |
| 54 | Linear Models |
| 54 | Combined Modality Therapy |
| 53 | Radiography |
| 53 | Practice Guidelines as Topic |
| 53 | Models, Theoretical |
| 53 | Antineoplastic Combined Chemotherapy Protocols (therapeutic use) |
| 52 | Self Report |
| 52 | Pennsylvania (epidemiology) |
| 52 | Brain (pathology) |
| 51 | Registries |
| 51 | Recurrence |
| 51 | Psychiatric Status Rating Scales |
| 51 | Odds Ratio |
| 51 | Breast Neoplasms (pathology) |
| 51 | Analysis of Variance |
| 50 | Randomized Controlled Trials as Topic |
| 50 | HEK293 Cells |
| 50 | Gene Expression Profiling |
| 50 | Apoptosis (drug effects) |
| 49 | Kinetics |
| 49 | Decision Making |
| 49 | Antineoplastic Agents (therapeutic use) |
| 48 | Biopsy |
| 48 | Base Sequence |
| 48 | Acute Disease |
| 47 | Models, Statistical |
| 47 | Gene Expression |
| 47 | Brain (physiology) |
| 47 | Aging (physiology) |
| 46 | ROC Curve |
| 46 | Genome-Wide Association Study |
| 45 | Image Processing, Computer-Assisted |
| 44 | Gene Expression Regulation |
| 44 | Depression (psychology) |
| 44 | Alleles |
| 43 | Phosphorylation |
| 43 | Mice, Inbred BALB C |
| 43 | Interpersonal Relations |
| 43 | HIV Infections (drug therapy) |
| 42 | Software |
| 42 | Signal Transduction (drug effects) |
| 42 | Regression Analysis |
| 42 | Health Knowledge, Attitudes, Practice |
| 42 | Feasibility Studies |
| 42 | Evidence-Based Medicine |
| 42 | Biomarkers (metabolism) |
| 41 | Neurons (physiology) |
| 41 | Anti-Bacterial Agents (therapeutic use) |
| 40 | Patient Selection |
| 40 | Cognition (physiology) |
| 40 | Blotting, Western |
| 39 | Signal Transduction (physiology) |
| 39 | RNA Interference |
| 39 | Protein Structure, Tertiary |
| 39 | Neurons (metabolism) |
| 38 | Macaca mulatta |
| 38 | Breast Neoplasms (drug therapy) |
| 38 | Apoptosis |
| 37 | Tomography, X-Ray Computed (methods) |
| 37 | Swine |
| 37 | RNA, Messenger (metabolism) |
| 37 | Obesity (complications) |
| 37 | Mitochondria (metabolism) |
| 37 | Clinical Trials as Topic |
| 37 | Cell Proliferation (drug effects) |
| 36 | Weight Loss |
| 36 | Patient Satisfaction |
| 36 | Motor Activity |
| 36 | Mice, Nude |
| 36 | Communication |
| 36 | Chronic Disease |
| 36 | Cell Differentiation |
| 36 | Brain Mapping |
| 36 | Brain (metabolism) |
| 35 | Cytokines (metabolism) |
| 35 | Cost-Benefit Analysis |
| 35 | Brain (physiopathology) |
| 34 | RNA, Messenger (genetics) |
| 34 | Protein Conformation |
| 34 | Oxidation-Reduction |
| 34 | Outcome Assessment (Health Care) |
| 34 | Gene Expression Regulation, Neoplastic |
| 34 | Drug Therapy, Combination |
| 34 | Cognition |
| 34 | Adenocarcinoma (pathology) |
| 34 | Activities of Daily Living |
| 33 | Sequence Analysis, DNA |
| 33 | Reoperation |
| 33 | Lung Neoplasms (pathology) |
| 33 | Lung (pathology) |
| 33 | Internet |
| 33 | Health Status |
| 33 | Carcinoma, Squamous Cell (pathology) |
| 32 | Phylogeny |
| 32 | HIV Infections (virology) |
| 31 | Ultrasonography |
| 31 | Polymorphism, Single Nucleotide (genetics) |
| 31 | Dendritic Cells (immunology) |
| 31 | Biomarkers, Tumor (metabolism) |
| 31 | Antineoplastic Agents (pharmacology) |
| 30 | Real-Time Polymerase Chain Reaction |
| 30 | Psychometrics |
| 30 | Neoplasms (therapy) |
| 30 | Membrane Proteins (metabolism) |
| 30 | Forecasting |
| 30 | Depression (epidemiology) |
| 30 | Biomarkers, Tumor (analysis) |
| 30 | Adaptation, Psychological |
| 29 | Transcription Factors (metabolism) |
| 29 | Tissue Engineering (methods) |
| 29 | Survival Rate (trends) |
| 29 | Societies, Medical |
| 29 | Smoking (epidemiology) |
| 29 | Reward |
| 29 | Research Design |
| 29 | Models, Neurological |
| 29 | Emotions |
| 29 | Drug Administration Schedule |
| 29 | Attitude of Health Personnel |
| 28 | User-Computer Interface |
| 28 | Polymerase Chain Reaction |
| 28 | Molecular Dynamics Simulation |
| 28 | Microscopy, Fluorescence |
| 28 | Heart Failure (therapy) |
| 28 | Health Behavior |
| 27 | Transfection |
| 27 | Temperature |
| 27 | Social Support |
| 27 | Smoking (psychology) |
| 27 | Promoter Regions, Genetic |
| 27 | Positron-Emission Tomography |
| 27 | Polymers (chemistry) |
| 27 | Parent-Child Relations |
| 27 | Mutation (genetics) |
| 27 | Microscopy, Confocal |
| 27 | Microbial Sensitivity Tests |
| 27 | Lung (metabolism) |
| 27 | Life Style |
| 27 | Inflammation (metabolism) |
| 27 | European Continental Ancestry Group (statistics & numerical data) |
| 27 | Cell Survival (drug effects) |
| 27 | Biomarkers, Tumor (genetics) |
| 27 | Binding Sites |
| 27 | Area Under Curve |
| 27 | Anterior Cruciate Ligament (surgery) |
| 27 | Aging |
| 27 | Age of Onset |
| 26 | Transcription Factors (genetics) |
| 26 | Skin Neoplasms (pathology) |
| 26 | Protein Transport |
| 26 | Postoperative Complications |
| 26 | Pain Measurement |
| 26 | Neoplasm Metastasis |
| 26 | European Continental Ancestry Group |
| 26 | Enzyme-Linked Immunosorbent Assay |
| 26 | Clinical Competence |
| 26 | Cell Movement |
| 26 | Antineoplastic Agents (administration & dosage) |
| 25 | Thermodynamics |
| 25 | Stress, Mechanical |
| 25 | Social Behavior |
| 25 | Reference Values |
| 25 | Reactive Oxygen Species (metabolism) |
| 25 | Photic Stimulation |
| 25 | Motor Activity (physiology) |
| 25 | Liver (pathology) |
| 25 | Length of Stay |
| 25 | Genetic Variation |
| 25 | Data Interpretation, Statistical |
| 25 | DNA Mutational Analysis |
| 25 | Cognitive Therapy (methods) |
| 25 | Cognition Disorders (etiology) |
| 25 | Chi-Square Distribution |
| 25 | Cell Membrane (metabolism) |
| 25 | Breast Neoplasms (metabolism) |
| 25 | Blood Pressure |
| 25 | Biomarkers |
| 25 | Anterior Cruciate Ligament Reconstruction (methods) |
| 25 | Alzheimer Disease (genetics) |
| 25 | Adolescent Behavior (psychology) |
| 24 | Women's Health |
| 24 | Reconstructive Surgical Procedures (methods) |
| 24 | Peptides (chemistry) |
| 24 | Pancreatic Neoplasms (pathology) |
| 24 | Neurons (drug effects) |
| 24 | Neoplasms (pathology) |
| 24 | Motivation |
| 24 | Molecular Structure |
| 24 | Knee Joint (surgery) |
| 24 | Intensive Care Units |
| 24 | Imaging, Three-Dimensional |
| 24 | Hydrogen-Ion Concentration |
| 24 | Hospitalization |
| 24 | Flow Cytometry |
| 24 | Exercise |
| 24 | Executive Function (physiology) |
| 24 | Disability Evaluation |
| 24 | Cooperative Behavior |
| 24 | Cardiovascular Diseases (epidemiology) |
| 24 | CD4-Positive T-Lymphocytes (immunology) |
| 24 | Aging (psychology) |
| 23 | Tissue Scaffolds |
| 23 | Surface Properties |
| 23 | Structure-Activity Relationship |
| 23 | Sleep (physiology) |
| 23 | Single-Blind Method |
| 23 | Recovery of Function |
| 23 | Reaction Time |
| 23 | Postoperative Complications (etiology) |
| 23 | Models, Psychological |
| 23 | Liver (metabolism) |
| 23 | HeLa Cells |
| 23 | Factor Analysis, Statistical |
| 23 | Cluster Analysis |
| 23 | Breast Neoplasms (genetics) |
| 23 | Blood Pressure (physiology) |
| 23 | Bipolar Disorder (psychology) |
| 23 | Biomarkers (analysis) |
| 23 | Administration, Oral |
| 22 | Up-Regulation |
| 22 | Treatment Failure |
| 22 | Transplantation, Homologous |
| 22 | Statistics as Topic |
| 22 | Sleep |
| 22 | Signal Transduction (genetics) |
| 22 | Risk Assessment (methods) |
| 22 | Reverse Transcriptase Polymerase Chain Reaction |
| 22 | Postoperative Complications (epidemiology) |
| 22 | Positron-Emission Tomography (methods) |
| 22 | Macrophages (metabolism) |
| 22 | Ligands |
| 22 | Injury Severity Score |
| 22 | Immunosuppressive Agents (therapeutic use) |
| 22 | Health Care Surveys |
| 22 | Head and Neck Neoplasms (pathology) |
| 22 | HIV-1 (genetics) |
| 22 | HIV Infections (complications) |
| 22 | Graft Survival |
| 22 | Gait (physiology) |
| 22 | Depressive Disorder, Major (psychology) |
| 22 | Depression (therapy) |
| 22 | Calibration |
| 22 | Bacterial Proteins (metabolism) |
| 22 | Bacterial Proteins (genetics) |
| 22 | Antidepressive Agents (therapeutic use) |
| 22 | Anti-Bacterial Agents (pharmacology) |
| 22 | Animals, Genetically Modified |
| 21 | Species Specificity |
| 21 | Qualitative Research |
| 21 | Oxidative Stress |
| 21 | Organ Size |
| 21 | Neoplasm Recurrence, Local (pathology) |
| 21 | Molecular Targeted Therapy |
| 21 | Materials Testing |
| 21 | Hospital Mortality |
| 21 | Hepatocytes (metabolism) |
| 21 | Genetic Association Studies |
| 21 | Electrocardiography |
| 21 | Data Collection |
| 21 | DNA Damage |
| 21 | Cues |
| 21 | Chemotherapy, Adjuvant |
| 21 | Cell Differentiation (physiology) |
| 21 | African Americans (statistics & numerical data) |
| 20 | Xenograft Model Antitumor Assays |
| 20 | Transcription, Genetic |
| 20 | T-Lymphocytes (immunology) |
| 20 | Stem Cells (cytology) |
| 20 | Self Concept |
| 20 | Proteins (chemistry) |
| 20 | Prosthesis Design |
| 20 | Patient Compliance |
| 20 | Parents (psychology) |
| 20 | Oxygen (blood) |
| 20 | Observer Variation |
| 20 | Neoplasms (metabolism) |
| 20 | Neoplasms (immunology) |
| 20 | Neoplasm Grading |
| 20 | Models, Animal |
| 20 | Membrane Proteins (genetics) |
| 20 | Lymph Nodes (pathology) |
| 20 | Interviews as Topic |
| 20 | Immunity, Innate |
| 20 | Hypertension (drug therapy) |
| 20 | Green Fluorescent Proteins (genetics) |
| 20 | Gestational Age |
| 20 | Gene Knockdown Techniques |
| 20 | Extracellular Matrix (metabolism) |
| 20 | Electroencephalography |
| 20 | Drug Discovery |
| 20 | Diet |
| 20 | Depression (diagnosis) |
| 20 | DNA (chemistry) |
| 20 | Curriculum |
| 20 | Cell Survival |
| 20 | Calcium (metabolism) |
| 20 | Cadaver |
| 20 | CD8-Positive T-Lymphocytes (immunology) |
| 20 | Blood Glucose (metabolism) |
| 20 | Antibodies, Monoclonal (therapeutic use) |
| 20 | Analgesics, Opioid (therapeutic use) |
| 20 | Adenocarcinoma (genetics) |
| 19 | Weight Gain |
| 19 | Walking (physiology) |
| 19 | Substance-Related Disorders (psychology) |
| 19 | Rotation |
| 19 | Psychomotor Performance (physiology) |
| 19 | Physician-Patient Relations |
| 19 | Peer Group |
| 19 | Patient Education as Topic |
| 19 | Obesity (epidemiology) |
| 19 | Neurons (pathology) |
| 19 | Neoplasm Invasiveness |
| 19 | Melanoma (pathology) |
| 19 | Insulin Resistance |
| 19 | Hypoglycemic Agents (therapeutic use) |
| 19 | HIV-1 (drug effects) |
| 19 | HIV Infections (immunology) |
| 19 | HIV Infections (epidemiology) |
| 19 | Glucose (metabolism) |
| 19 | Gene Deletion |
| 19 | Focus Groups |
| 19 | Ethnic Groups |
| 19 | Educational Status |
| 19 | Disease Management |
| 19 | Depressive Disorder (psychology) |
| 19 | Depression (physiopathology) |
| 19 | Attitude to Health |
| 19 | Artificial Intelligence |
| 19 | Age Distribution |
| 19 | African Americans |
| 18 | Range of Motion, Articular |
| 18 | Radiotherapy Dosage |
| 18 | Rabbits |
| 18 | Particle Size |
| 18 | Neoplasms (genetics) |
| 18 | NF-kappa B (metabolism) |
| 18 | Macrophages (immunology) |
| 18 | Lung Transplantation |
| 18 | Kidney (pathology) |
| 18 | Inflammation (pathology) |
| 18 | Infant, Premature |
| 18 | In Situ Hybridization, Fluorescence |
| 18 | Image Processing, Computer-Assisted (methods) |
| 18 | Image Interpretation, Computer-Assisted (methods) |
| 18 | Hospitalization (statistics & numerical data) |
| 18 | History, 20th Century |
| 18 | Hemodynamics |
| 18 | Heart Failure (physiopathology) |
| 18 | Health Surveys |
| 18 | HIV Infections (prevention & control) |
| 18 | Gene Expression Regulation, Developmental |
| 18 | European Continental Ancestry Group (genetics) |
| 18 | Epithelial Cells (metabolism) |
| 18 | Enzyme Inhibitors (pharmacology) |
| 18 | Emotions (physiology) |
| 18 | Dogs |
| 18 | Dietary Supplements |
| 18 | Depression (complications) |
| 18 | DNA-Binding Proteins (metabolism) |
| 18 | Crystallography, X-Ray |
| 18 | Cerebrovascular Circulation (physiology) |
| 18 | Biological Evolution |
| 18 | Anxiety (psychology) |
| 18 | Antihypertensive Agents (therapeutic use) |
| 18 | Adenosine Triphosphate (metabolism) |
| 18 | Action Potentials (physiology) |
| 17 | White Matter (pathology) |
| 17 | Tissue Donors |
| 17 | Substance-Related Disorders (epidemiology) |
| 17 | Stroke (etiology) |
| 17 | Smoking (adverse effects) |
| 17 | Risk-Taking |
| 17 | Proto-Oncogene Proteins (genetics) |
| 17 | Postoperative Period |
| 17 | Pedigree |
| 17 | Obesity, Morbid (surgery) |
| 17 | Neural Pathways (physiology) |
| 17 | Neoplasms (drug therapy) |
| 17 | Mobility Limitation |
| 17 | MicroRNAs (metabolism) |
| 17 | Lung Neoplasms (drug therapy) |
| 17 | Lung (immunology) |
| 17 | Length of Stay (statistics & numerical data) |
| 17 | Inflammation (immunology) |
| 17 | Green Fluorescent Proteins (metabolism) |
| 17 | Genetic Predisposition to Disease (genetics) |
| 17 | Gene Expression Regulation (drug effects) |
| 17 | Diabetes Mellitus, Type 2 (complications) |
| 17 | Depression (etiology) |
| 17 | Decision Support Techniques |
| 17 | DNA Repair |
| 17 | Counseling |
| 17 | Contrast Media |
| 17 | Colorectal Neoplasms (pathology) |
| 17 | Carcinoma, Squamous Cell (genetics) |
| 17 | Canada |
| 17 | Breast Neoplasms (surgery) |
| 17 | Brain Mapping (methods) |
| 17 | Body Weight |
| 17 | Antipsychotic Agents (therapeutic use) |
| 17 | Antineoplastic Agents (adverse effects) |
| 17 | Anterior Cruciate Ligament Injuries |
| 17 | Affect |
| 16 | Water (chemistry) |
| 16 | Translational Medical Research |
| 16 | Suicidal Ideation |
| 16 | Stress, Psychological (psychology) |
| 16 | Sequence Alignment |
| 16 | Schizophrenia (pathology) |
